Conference Coverage

Adherence to follow-up lung cancer screening not optimal


 

Former smokers’ adherence to annual follow-up screening for lung cancer was found to be less than optimal, according to a study to be presented at the CHEST 2018 annual meeting.

Paul B. Brasher, MD, and his colleagues from the Thoracic Oncology Research Group at the Medical University of South Carolina in Charleston studied adherence to recommended low-dose computed tomography (LDCT) among Veterans Affairs patients who were at high risk for lung cancer and whose baseline LDCTs were negative.

A total of 2,106 veterans aged 55-80 years who had at least a 30-pack year smoking history were initially screened within the Veterans Health Administration Lung Cancer Screening Demonstration Project. The study tracked 1,120 of these patients for 18 months to determine their adherence to annual LDCT screening; the rate of adherence was 77.6%.

View the abstract here: https://journal.chestnet.org/article/S0012-3692(18)31772-0/fulltext

The study will be presented in the session Lung Cancer Screening: New Questions and New Answers, Tuesday, Oct. 9, 8:45 a.m., Convention Center 207A.

Recommended Reading

The T-cell repertoire in NSCLC: Therapeutic implications
Journal of Clinical Outcomes Management
Imfinzi approved for stage III unresectable NSCLC
Journal of Clinical Outcomes Management
Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States
Journal of Clinical Outcomes Management
Qualitative assessment of organizational barriers to optimal lung cancer care in a community hospital setting in the United States
Journal of Clinical Outcomes Management
Upfront NGS testing of metastatic NSCLC saves money, time
Journal of Clinical Outcomes Management
Broad genomic testing of NSCLC in community oncology disappoints
Journal of Clinical Outcomes Management
Low-dose CT fails to improve small cell lung cancer survival
Journal of Clinical Outcomes Management